FIELD: pharmacology.
SUBSTANCE: invention is a sterilized composition used in the cosmetic or pharmaceutical field containing at least one crosslinked hyaluronic acid having a crosslinking ratio of X of 0.1 to 0.2 or one of its biologically acceptable salts individually or in a mixture and magnesium ascorbyl phosphate with mass ratio between the content of hyaluronic acid or one of its salts [HA] and magnesium ascorbyl phosphate [MAP], [HA]/[MAP] content exceeding or equal to 1, the magnesium ascorbyl phosphate content being in the range m 0.03 to 1 wt % based on the total weight of the composition, the elasticity G' of which is maintained or increased after sterilisation and is in the range of 5 to 400 Pa.
EFFECT: improvement or preservation of the rheological characteristics of the elasticity index after sterilisation.
22 cl, 2 dwg, 12 tbl, 17 ex
